Abstract:IntroductionIn addition to its direct proinflammatory activity, extracellular high mobility group box protein 1 (HMGB1) can strongly enhance the cytokine response evoked by other proinflammatory molecules, such as lipopolysaccharide (LPS), CpG-DNA and IL-1β, through the formation of complexes. Extracellular HMGB1 is abundant in arthritic joint tissue where it is suggested to promote inflammation as intra-articular injections of HMGB1 induce synovitis in mice and HMGB1 neutralizing therapy suppresses development of experimental arthritis. The aim of this study was to determine whether HMGB1 in complex with LPS, interleukin (IL)-1α or IL-1β has enhancing effects on the production of proinflammatory mediators by rheumatoid arthritis synovial fibroblasts (RASF) and osteoarthritis synovial fibroblasts (OASF). Furthermore, we examined the toll-like receptor (TLR) 4 and IL-1RI requirement for the cytokine-enhancing effects of the investigated HMGB1-ligand complexes.MethodsSynovial fibroblasts obtained from rheumatoid arthritis (RA) and osteoarthritis (OA) patients were stimulated with HMGB1 alone or in complex with LPS, IL-1α or IL-1β. Tumour necrosis factor (TNF) production was determined by enzyme-linked immunospot assay (ELISPOT) assessment. Levels of IL-10, IL-1-β, IL-6 and IL-8 were measured using Cytokine Bead Array and matrix metalloproteinase (MMP) 3 production was determined by ELISA.ResultsStimulation with HMGB1 in complex with LPS, IL-1α or IL-1β enhanced production of TNF, IL-6 and IL-8. HMGB1 in complex with IL-1β increased MMP production from both RASF and OASF. The cytokine production was inhibited by specific receptor blockade using detoxified LPS or IL-1 receptor antagonist, indicating that the synergistic effects were mediated through the partner ligand-reciprocal receptors TLR4 and IL-1RI, respectively.ConclusionsHMGB1 in complex with LPS, IL-1α or IL-1β boosted proinflammatory cytokine- and MMP production in synovial fibroblasts from RA and OA patients. A mechanism for the pathogenic role of HMGB1 in arthritis could thus be through enhancement of inflammatory and destructive mechanisms induced by other proinflammatory mediators present in the arthritic joint.

High mobility group box protein 1 in complex with lipopolysaccharide or IL-1 promotes an increased inflammatory phenotype in synovial fibroblasts

HMGB1 acts in synergy with lipopolysaccharide in activating rheumatoid synovial fibroblasts via p38 MAPK and NF- B signaling pathways

HMGB1 acts in synergy with lipopolysaccharide in activating rheumatoid synovial fibroblasts via p38 MAPK and NF-κB signaling pathways.

High mobility group box chromosomal protein 1: a novel proinflammatory mediator in synovitis

The effect of high mobility group box 1 with interleukin-1β or lipopolysaccharide on the proliferation and inflammatory phenotype of synoviocytes in rheumatoid arthritis

[Role of HMGB1 in Rheumatic Diseases].

High mobility group box chromosomal protein 1 promotes matrix metalloproteinase-13 production in synovial fibroblasts

Role and Mechanisms of HMGB1 in the Pathogenesis of Rheumatoid Arthritis

Hmgb1 Enhances The Proinflammatory Activity Of Lipopolysaccharide By Promoting The Phosphorylation Of Mapk P38 Through Receptor For Advanced Glycation End Products

HMGB1 Contributes to Osteoarthritis of Temporomandibular Joint by Inducing Synovial Angiogenesis.

High Mobility Group Box 1 Activates Toll Like Receptor 4 Signaling in Hepatic Stellate Cells

Overexpression of HMGB1 A-box Reduced IL-1β-induced MMP Expression and the Production of Inflammatory Mediators in Human Chondrocytes.

HMGB1 as a DNA-binding cytokine

High-mobility group box 1 accelerates lipopolysaccharide-induced lung fibroblast proliferation in vitro : involvement of the NF- κ B signaling pathway

[Expression of High Mobility Group Box Chromosomal Protein 1 in Peripheral Blood of Patients with Rheumatoid Arthritis].

Increased expression of pro-inflammatory cytokines and metalloproteinase-1 by TGF-beta1 in synovial fibroblasts from rheumatoid arthritis and normal individuals

Expression of high mobility group box chromosomal protein 1 and its modulating effects on downstream cytokines in systemic lupus erythematosus.

Inhibition of HMGB1 Suppresses Inflammation and Catabolism in Temporomandibular Joint Osteoarthritis Via NF-κB Signaling Pathway.

HMGB1 participates in LPS-induced acute lung injury by activating the AIM2 inflammasome in macrophages and inducing polarization of M1 macrophages via TLR2, TLR4, and RAGE/NF-B signaling pathways

Relationship of high mobility group boxl and inflammation

Targeting Inflammation Driven by HMGB1